Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Type: Information update
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 15 of 45 items.
Ranitidine products recalled because of a nitrosamine impurity
AlertInformation update | 2022-03-11
Medical Device Respirator recalls
AlertInformation update | 2020-06-23
Get ready for this summer’s heat with expert tips!
AlertInformation update | 2020-06-22
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
AlertInformation update | 2020-04-25
No scientific evidence that ibuprofen worsens COVID-19 symptoms
AlertInformation update | 2020-03-20
Cybersecurity vulnerabilities associated with some medical devices with Bluetooth Low Energy chips
AlertInformation update | 2020-03-11
Alcohol, Cannabis and Drug Use During the Holiday Season
AlertInformation update | 2019-12-17
Health Canada evaluating NDMA in metformin drugs
AlertInformation update | 2019-12-05
Unauthorized soft-shelled hyperbaric chambers may pose serious health risks
AlertInformation update | 2019-10-25
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
AlertInformation update | 2019-09-17
Needle-free dermal filler devices used for cosmetic skin treatments are not authorized in Canada and may pose health risks
AlertInformation update | 2019-09-13
Health Canada assessing NDMA in ranitidine
AlertInformation update | 2019-09-13
Information Update - Health Canada warns of potential risk of pulmonary illness associated with vaping products
AlertInformation update | 2019-09-04
Status of non-absorbable synthetic surgical mesh for the transvaginal repair of pelvic organ prolapse in Canada
AlertInformation update | 2019-07-26